Drug delivery

In 2022, Cytiva and The Translational Scientist explored bench-to-bedside challenges in the “Hurdles and High Jumps” series, offering resources to aid

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

TUM Researchers create organoid that emulates the development of the human heart

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors

PULSED – a self-sealing drug delivery depot – enables precise timing and tunable release of therapeutic doses

An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies

Eva Cuypers discusses the vast potential of MSI, her work in cancer research, and the importance of researcher-clinician relationships

Can digital tools help cell and gene therapy evolve?